Lyka Labs has received an approval for sale of manufacturing facilities of formulations located at Tarapur in state of Maharashtra
Lyka Labs is currently trading at Rs. 15.40, up by 0.35 points or 2.33 % from its previous closing of Rs. 15.05 on the BSE.
The scrip opened at Rs. 15.10 and has touched a high and low of Rs. 15.65 and Rs. 15.10 respectively. So far 4731 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 21.70 on 13-Jun-2014 and a 52 week low of Rs. 8.46 on 07-Aug-2013.
Last one week high and low of the scrip stood at Rs. 18.40 and Rs. 15.00 respectively. The current market cap of the company is Rs. 33.23 crore.
The promoters holding in the company stood at 23.30 % while Institutions and Non-Institutions held 4.93 % and 71.78 % respectively.
Lyka Labs has received an approval for sale of manufacturing facilities of formulations located at Tarapur in state of Maharashtra. The board of directors at its meeting held on July 14, 2014 has approved for the same. The board also approved to seek approval of shareholders through Postal Ballot for sale of manufacturing facilities.
Lyka Labs is engaged in the manufacture of pharmaceutical products. It also manufactures Veterinary products including injections, powders, creams and suspensions. The company offers various surgical disposables, such as syringes, surgical blades, cotton crepe bandage and first aid kits.
